600511 国药股份
2023/122022/122021/122020/122019/12

盈利能力分析
净资产收益率 ROE (%)14.31114.55114.48212.58116.226
总资产报酬率 ROA (%)6.9166.8176.6305.6327.019
投入资产回报率 ROIC (%)11.29411.48711.62110.15312.985

边际利润分析
销售毛利率 (%)8.0318.4017.8147.7838.753
营业利润率 (%)5.9255.9235.2674.7385.457
息税前利润/营业总收入 (%)5.6445.8445.2224.7325.459
净利润/营业总收入 (%)4.6974.6794.1503.7384.212

收益指标分析
经营活动净收益/利润总额(%)85.36584.82886.60582.84093.736
价值变动净收益/利润总额(%)12.61610.84911.59011.5054.722
营业外收支净额/利润总额(%)-0.460-0.262-0.1010.215-0.392

偿债能力分析
流动比率 (X)2.0352.0221.9301.9681.868
速动比率 (X)1.7501.7311.6541.6961.579
资产负债率 (%)45.97446.43748.74947.42449.744
带息债务/全部投入资本 (%)15.01216.49814.20815.51315.704
股东权益/带息债务 (%)531.600472.573563.460518.621515.675
股东权益/负债合计 (%)105.737103.38493.59596.89087.555
利息保障倍数 (X)-22.238-92.200-132.292-280.550230.979

营运能力分析
应收账款周转天数 (天)53.26045.32643.22672.98183.700
存货周转天数 (天)30.24231.23727.58430.96729.604